bioXXmed AG (FRA:T5O)
Germany · Delayed Price · Currency is EUR 1.020
+0.020 (2.00%)
Last updated: Oct 6, 2026, 7:36 PM CET
bioXXmed AG Market Cap
bioXXmed AG has a market cap or net worth of €277.3 thousand as of October 8, 2026. It is the 50,720th most valuable company in the world and the 704th biggest in Germany. Its market cap has increased by 70.00% in one year.
Market Cap
277.30K
Enterprise Value
389.30K
Revenue
-269.00
Global Rank
Country Rank
#704 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since December 13, 2006, bioXXmed AG's market cap has decreased from 16.12M to 277.30K, a decrease of -98.28%. That is a compound annual growth rate of -18.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 277.30K | 827.28% |
| Dec 30, 2025 | 29.91K | -95.56% |
| Dec 30, 2024 | 673.01K | -88.20% |
| Dec 30, 2022 | 5.70M | -69.02% |
| Dec 30, 2021 | 18.41M | -70.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 86.40M |
| 2invest AG | 43.75M |
| Biomark Diagnostics | 31.52M |
| Vidac Pharma Holding | 22.10M |
| Paion AG | 331.72K |
| co.don AG | 213.79K |
| MagForce AG | 76.43K |